Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Refractory AL Amyloidosis
Beijing
Refractory AL Amyloidosis Clinical Trials in Beijing
1 recruiting
Beijing, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.
9 enrolled
9 locations
NCT07250269
Feedback